Genasense data released

In briefing documents released in advance of Monday's meeting of the Oncologic Drugs Advisory Committee, FDA said that approval of Genasense oblimersen from Genta would require the agency to change its standards for assessing the

Read the full 357 word article

How to gain access

Continue reading with a
two-week free trial.